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Pisonia aculeata is traditionally used in treatment of liver disorder 
and thought to have a protective effect which may be beneficial to 
reduce symptoms of hepatotoxicity. The current study aimed to 
evaluate the scientific merit of these anecdotal claims in an in vivo 
model. Methanolic extract of leaves of Pisonia aculeata (250 and 
500 mg/kg, p.o.) showed a remarkable hepatoprotective and 
antioxidant activity against  Rifampicin and Isoniazid induced 
hepatotoxicity as judged from the serum marker enzymes and 
antioxidant levels in liver tissues. Acetaminophen induced a 
significant rise in aspartate amino transferase (AST), alanine 
amino transferase (ALT), alkaline phosphatase (ALP), total 
bilirubin, gamma glutamate transpeptidase (GGTP), lipid peroxidase 
(LPO) with a reduction of total protein, superoxide dismutase 
(SOD), catalase, glutathione peroxidase (GPx), reduced 
glutathione (GSH), Glutathione reductase (GR), Vitamin C and E. 
Treatment of rats with different doses of plant extract (200 and 300 
mg/kg) significantly (P<0.001) altered serum marker enzymes and 
antioxidant levels to near normal against acetaminophen treated rats. 
Also the extract was effectively altered the drug metabolizing 
enzymes such as Cytochrome P450, NADPH   Cytochrome C 
reductase and glutathione S transferase. The activity of the extract at 
dose of 500 mg/kg was comparable to the standard drug, silymarin 
(50 mg/kg, p.o.). Histopathological changes of liver sample were 
compared with respective control. Results indicate the 
hepatoprotective and antioxidant properties of Pisonia aculeata 
against rifampicin and isoniazid -induced hepatotoxicity in rats.  
Keywords: Pisonia aculeata; Rifampicin; Isoniazid; Biochemical 
parameters; Antioxidants; Lipid peroxidation; Histopathology. 
 
Introduction 
Herbal medicines have recently attracted 
much attention as alternative medicines 
useful for treating or preventing life style 
related disorders and relatively very little 
knowledge is available about their mode of 
action. There has been a growing interest in 
the analysis of plant products which has 
stimulated intense research on their potential 
health benefits (1). Liver, the key organ of 
metabolism and excretion has an immense 
task of detoxification of xenobiotics, 
environmental pollutants and 
chemotherapeutic agents. Hence, this organ 
is subjected to variety of diseases and 
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disorders. Several hundred plants have been 
examined for use in a wide variety of liver 
disorders. Antioxidants play an important 
role in inhibiting and scavenging free 
radicals and thus providing protection 
against infections and degenerative 
diseases (2).  
 
Pisonia aculeata (Nyctaginaceae) is nearly 
pantropical, found throughout the new world 
tropics and is considered introduced in 
Africa, Asia, and the Phillipines (3). Pisonia 
aculeata is a large scandent shrub distributed 
throughout India. The leaves and bark are 
used by the tribes and native medical 
practitioners to treat various ailments 
including liver disorders, inflammation, 
swelling, cough and tumours (4).Preliminary 
phytochemical screening of the extracts 
reveals the presence of alkaloids, phenolic 
compounds, tannins, saponnins and 
flavonoids. Hence, the present study is 
aimed to evaluate the hepatoprotective and 
antioxidant activity of methanol extract of 
the leaves of Pisonia aculeate against 
rifampicin and isoniazid (RCIN and INH) 
induced hepatotoxicity in rats. 
 
Materials and Methods 
Plant material and extraction:  
The plants Pisonia aculeata were collected 
in the month of July 2010 from the 
Tirunelveli Dist, Tamilnadu, India. The plant 
material was taxonomically identified by the 
Botanical Survey of India, Coimbatore, 
Tamilnadu. A voucher specimen has been 
kept in our laboratory for future reference. 
The plants were dried in the shade and 
pulverized. The powder was treated with 
petroleum ether for dewaxing as well as to 
remove chlorophyll. The powder was then 
packed into soxhlet apparatus and 
subjected to hot continuous percolation 
using methanol (95% v/v) as solvent. The 
extract was concentrated under vacuum and 
dried in a vacuum desiccator (yield 4.1 
%w/w) and then suspended in 5% gum 
acacia for hepatoprotective studies. 
 
Animals:  
Male Wistar rats (125-150 g) and Swiss 
albino mice (20-25 g) were procured from 
Sri Venkateswara Enterprises, Bangalore, 
India. They were housed in microloan boxes 
with standard laboratory diet and water ad 
libitum. The study was conducted after 




Rifampicin and isoniazid were purchased 
from Lupin Ltd., Mumbai, India. 1-chloro2, 
4-dinitro benzoic acid (CDNB), 5, 5-dithio-
bis-2-nitro benzoic acid (DTNB) and 
reduced glutathione (GSH) were supplied by 
Sisco Research Laboratories Pvt. Ltd., 
Mumbai, India. Thiobarbituric acid was 
purchased from E-Merck, India. All other 
chemicals used were of analytical grade. 
 
Acute toxicity:  
The acute toxicity of the MPA was evaluated 
in mice using the up and down procedure 
(OECD, 2001). Mice received alcohol 
extract at various doses (500-2000 mg/kg) 
orally by gavage. The animals were 
observed for toxic symptoms continuously 
for the first 4 h after dosing. Finally, the 
number of survivors was noted after 24 h. 
 
Experimental design:  
Rats were divided into five groups, each 
group consisting of six animals. 
 
Group I: Controls received the vehicle 
viz.normal saline (2 ml/kg). 
Group II: Received RCIN and INH (100 +50 
mg/kg p.o.)[5] at every 72 h for 
21 days. 
GroupIII: Received silymarin 50 mg/kg p.o. 
for 21 days and simultaneously 
administered RCIN and INH (100 
+50 mg/kg p.o.) every 72 h. 
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Group IV: Received MPA 250 mg/kg p.o for 
21 days and simultaneously 
administered a RCIN and  INH 
(100 +50 mg/kg p.o.) every 72 h. 
GroupV: Received MPA 500 mg/kg p.o. for 
21 days and simultaneously 
administered RCIN and INH    
(100 +50 mg/kg p.o.)every 72 h. 
 
At the end of all experimental methods, all 
the animals were sacrificed by cervical 
decapitation. Blood samples were collected, 
allowed to clot. Serum was separated by 
centrifuging at 2500 rpm for 15 min and 
analyzed for various biochemical 
parameters. 
 
Assessment of liver function:  
Biochemical parameters i.e., aspartate amino 
transferase(AST) (6) alanine amino 
transferase(ALT) (6), alkaline phosphatase 
(ALP) (7), γ-glutamate transpeptidase 
(GGTP) (8), total bilirubin (9) and total 
protein (10) were analyzed according to the 
reported methods. The liver was removed, 
weighed and morphological changes were 
observed. A 10% of liver homogenate was 
used for antioxidant studies such as lipid 
peroxidation (LPO) (11), superoxide 
dismutase (SOD)( 12),  catalase (13),  
glutathione peroxidase (GPx) (14). Another 
portion of liver homogenate was centrifuged 
at 100,000 X g for 60 min at 40 C for 
microsomal separation and was used to 
assay for cytochrome P450 (15), cytochrome 
c reductase (16) and glutathione S-
transferase (GST) (17). were analyzed 
according to the reported methods. The 
liver was removed, weighed and 
morphological changes were observed. A 
portion of liver was fixed in 10% formalin 
for histopathological studies. 
 
Histopathological studies:  
Liver slices fixed for 12 hrs in Bouin’s 
solution were processed for paraffin 
embedding following standard micro 
techniques (18). 5μm sections of liver 
grained with alum haematoxylin and eosin 
were observed microscopically for 
histopathological changes.  
 
Statistical analysis:  
The values were expressed as mean ± SEM. 
Statistical analysis was performed by one 
way analysis of variance (ANOVA) 
followed by Tukey multiple comparison test 
and data on liver weight variations were 
analyzed using Student’s ‘t’ test. P values < 
0.05 were considered as significant.  
 







ALT       
U/L 











Normal     
(normal  
saline) 
2 ml/kg 132.7 ± 1.18 76.25 ± 1.78 196.5 ± 2.45 0.8 ± 0.05 8.13 ± 0.46 75.34±1.05 
RCIN and 
INH 
50+100 210.3 ± 2.85a 165.4±1.15 a 376.8±3. 42 a 1.24±0.06a 6.45±0.18b 189.5 ± 2.67a 
Silymarin 50 152.4±1.26 a,c 101.3±1.38a,c 223.5±2.06a,c 0.93±0.04d 7.8 ± 0.25e 102.6±1.21a,c 
250 183.5 ±1.52a,c 140.9±1.65a,c 316.24±2.34 a,c 1.14±0.07b 7.1 ± 0.14  149.3±1.14a,c MPA  
500 165.7 ±1.34 a,c 126.5±1.23a,c 258.9±2.45 a,c 1.06±0.05b 7.5 ± 0.16 116.4±1.34a,c
N= 6; Values are expressed as mean ± SEM 
aP<0.001; bP<0.01Vs Normal 
cP<0.001; dP<0.01;  eP<0.05 Vs RCIN and INH  
Data were analysed by one way ANOVA followed by Tukey multiple comparison test    
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N=6; Values are expressed as mean ± SEM 
aP<0.001; bP<0.01 Vs control 
cP<0.01;  dP<0.05   Vs RCIN and INH 
Data were analysed by one way ANOVA followed by Tukey multiple comparison analysis. 
 
Results 
The effect of MPA on serum marker 
enzymes are presented in table 1.The levels 
of serum AST, ALT, ALP, total bilirubin, 
GGTP were markedly elevated and that of 
protein decreased in RCIN and INH treated 
animals, indicating liver damage. 
Administration of MPA at the doses of 250 
and 500 mg/kg remarkably prevented RCIN 
and INH -induced hepatotoxicity in a dose 
dependent manner. 
 
Analysis of LPO levels by paracetamol acid 
reaction showed a significant (P<0.001) 
increase in the INH and RCIN treated rats. 
Treatment with MPA (250 mg/kg and 500 
mg/kg) significantly (P<0.001) prevented the 
increase in LPO level which was brought to 
near normal. The effect of MPA was 
comparable with that of standard drug 
silymarin (Fig 1). 
 
RCIN and INH treatment caused a 
significant (P<0.001) decrease in the level of 
SOD, catalase, GPx, GR, GSH, Vit C and 
Vit E in liver tissue when compared with 
control group (table 2). The treatment of 
MPA at the doses of 250 and 500 mg/kg 
resulted in a significant increase of enzymic 
and non enzymic antioxidants when 
compared to RCIN and INH treated rats. The 
liver of silymarin treated animals also 
showed a significant increase in antioxidant 
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Table 2. Effect of MPA on enzymic and non-enzymic antioxidants level in RCIN and INH -induced 
hepatotoxicity rats. 
Treatment Dose (mg/kg) SOD CAT GPx GR GSH Vit -C Vit -E 
Normal      
(normal  
saline) 
2 ml/kg 46.7 ± 1.12 78 ± 3.10 28.45 ± 1.16 3.46 ± 0.14 2.04±0.06 1.75±0.005 0.65±0.003 
RCIN 
and INH 50+100 24.8±1.26
 a 36±1.14 a 14.52±0.85a  1.73±0.08 a 1.02±0.09 a 0.89±0.007 a 0.34±0.004 a 
Silymarin 50 41.6±1.45 c 72±2.06 c 25.64±1.12c 3.08±0.27c 1.91±0.04 c 1.59±0.008a,c 0.57±0.005 a,c
250 30.4±1.18a,d 46±1.27a,e 18.93±0.93a,d 2.23± 0.15 a 1.34±0.07 a,d 1.18±0.005a,c 0.42±0.008 a,cMPA 500 38.7±1.28b,c 63±1.35a,c 22.67±1.06b,c 2.89± 0.16c 1.82±0.05c 1.37±0.006a,c 0.51±0.006a,c 
N=6; Each value is expressed as mean ± S.E.M.  
aP<0.001; bP<0.01  Vs Control                    cP<0.001; dP<0.05 ; eP<0.01  Vs RCIN and INH 
Data were analysed by one way ANOVA followed by Tukey Kramer multiple comparison test    
Units: SOD-1U=amount  of enzyme that inhibits the antioxidants  of pyrogallol by 50%; CAT- µmoles of H2O2  
consumed/min/mg protein; GPx-µmoles of GSH oxidized/min/mg  protein; GSH-µg/mg protein; GR-nmoles  of 
NADPH  oxidized/min/mg  protein; Vitamin C and Vitamin E- µg/mg protein 
 
Table 3. Effect of MPA on phase I and phase II enzymes in RCIN and INH induced hepatotoxicity in rats. 
Treatment Dose (mg/kg) Cyt p450 NADPH cyto C reductase GST 
Normal                 
(normal saline) 2 ml/kg 2.36 ± 0.04 96.53 ± 1.17 2.07 ± 0.06 
RCIN and INH 50 + 100 5.27 ± 0.06a 165.23 ± 2.35a 4.36 ± 0.12 a
Silymarin  50 2.73 ± 0.05b,c 113.45 ± 1.42 a,c 2.47±0.08 b,c
250 4.18 ± 0.08 a,c 142.53 ± 1.78a,c 3.94±0.05 a,dMPA 500 2.95 ± 0.07a,c 120.86 ± 2.69a,c 2.86±0.09a,c 
N=6 animals in each group; Each value is expressed  as mean ± SEM.   
aP<0.001; bP<0.01  Vs Control                     cP<0.001; dP<0.05  Vs  RCIN and INH 
Data were analysed by one way ANOVA followed by Tukey Kramer multiple comparison test    
 
Table 3.  depicts the effect of P. aculeata 
on phase–I & II enzymes in liver of control 
and experimental animals. There found to 
be a significant (P<0.001) increase in the 
activities of Cyt P450, NADPH   Cyt C 
reductase and GST in group RCIN and INH 
intoxicated animals when compared with 
control animals. P. aculeata ex t rac t  
treatment (250 and 500  mg/kg) resulted in 
a significant (P<0.001) decreases in phase-I 
and phase II enzyme levels. These enzyme 
activities was completely restored to the 
normal level by treatment with the P. 
aculeata extract at 500 mg/kg. As a positive 
hepatoprotective control, silymarin (50 
mg/kg) also significantly restored Cyt 
P450,,  NADPH   Cyt C reductase and GST 
enzyme activities to the normal level under 
the same conditions 
 
Morphological observations showed an 
increased size and enlargement of the liver 
in RCIN and INH treated groups. These 
changes were reversed by treatment with 
silymarin and also MPA at the doses tested 
(Fig 2). Histopathological studies, showed 
RCIN and INH to produced extensive 
vascular degenerative changes and 
centrilobular necrosis in hepatocytes. 
Treatment with different doses of MPA 
produced mild degenerative changes and 
absence of centrilobular necrosis when 
compared with control. All these results 
indicate a hepatoprotective potential of the 
extract. 
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N=6; Values are expressed as mean ± SEM 
aP< 0.001; bP< 0.01 Vs Normal 
cP< 0.001 Vs RCIN and INH 
Data were analysed by one way ANOVA followed by Tukey multiple comparison test. 
 
Discussion 
Drug-induced hepatotoxicity is a potentially 
serious adverse effect of the currently used 
anti-tubercular chemotherapeutic regimens 
containing RCIN and INH. The conversion 
of monoacetyl hydrazine, a metabolite of 
INH, to a toxic metabolite via cytochrome 
P450 leads to hepatotoxicity. RCIN induces 
cytochrome P450 enzyme resulting an 
increased production of toxic metabolites 
from acetyl hydrazine (AcHz). RCIN can 
also increase the metabolism of INH to 
isonicotinic acid and hydrazine, both of 
which are hepatotoxic.  
 
The plasma half life of AcHz (metabolite of 
INH) is shortened by RCIN and AcHz is 
quickly converted to its active metabolites 
by increasing the oxidative elimination rate 
of AcHz, which is related to the higher 
incidence of liver necrosis caused by RCIN 
and INH combination (19). In addition to 
these mechanisms; oxidative stress induced 
hepatic injury is one of the important 
mechanisms in hepatotoxicity produced by 
anti-tubercular drugs (20,21).Earlier it has 
been well documented that both ALT and 
AST are considered among the most 
sensitive markers to assess hepatocellular 
damage leading to liver cell necrosis (22-
23).  
 
ALP, which is secreted from the lysosomes, 
is also a marker enzyme for assessing liver 
damage. Slight to moderate increases in ALP 
(1-2 times normal) occurred in liver 
disorders (24). γGT has been claimed to be 
an extremely sensitive test and marker of 
hepatic damage. Estimating the activities of 
serum marker enzymes, like AST, ALT, 
ALP, total bilirubin, γGT, can make 
assessment of liver function. When liver cell 
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plasma membrane is damaged, a variety of 
enzymes normally located in the cytosol are 
released in to the blood stream. Their 
estimation in the serum is a useful 
quantitative marker of the extent and type of 
hepatocellular damage.  
 
The enhanced activities of these serum 
marker enzymes observed in RCIN and INH 
treated rats in our study correspond to the 
extensive liver damage induced by RCIN 
and INH. Results indicate that MPA 
administration could blunt RCIN and INH -
induced increase in activities of different 
marker enzymes of heptocellular injury, viz. 
AST, ALT, ALP, total bilirubin, γGT and 
total protein, (Table 1) suggesting that MPA 
possibly has a protective influence against 
RCIN and INH induced hepatocellular injury 
and degenerative changes. Antitubercular 
drugs mediated oxidative damage is 
generally attributed to the formation of free 
radicals, which act as stimulator of lipid 
peroxidation and source for destruction and 
damage to the cell membrane (25).  
 
The combination of RCIN and INH was 
reported to result in higher rate of inhibition 
of biliary secretion and an increase in liver 
cell lipid peroxidation, and cytochrome P-
450 was thought to be involved in the 
synergistic effect of RCIN and INH (26). 
However, its role in INH-induced 
hepatotoxicity is unclarified, as INH itself is 
an inducer of CYP2E1 (27). In previous 
report suggested that, there did not seem to 
be clear evidence that INH proves much 
more injuries than RIF and, in this 
connection, they consider that it is the 
combination of these two drugs that confer 
the additive, or even synergistic, potential of 
liver toxicity than either agent alone, as 
conjectured (28-29). In our study, RCIN and 
INH treatment produced the elevation in the 
levels of LPO. Treatment of the rats with 
MPA significantly reduced the elevated 
levels of LPO. 
Alterations of various cellular defense 
mechanisms consisting of enzymatic and 
non-enzymatic antioxidant components 
[superoxide dismutase (SOD), catalase, 
glutathione peroxidase (GPx), reduced 
glutathione, Glutathione reductase, Vitamin 
C and E have been reported in RCIN and 
INH -induced hepatoxicity (Table 3). The 
RCIN and INH administered animals 
exhibited significantly (p<0.001) low levels 
of hepatic enzymatic and non-enzymatic 
antioxidant components, and significantly 
increased with co-administration of MPA 
(250 and 500 mg/kg) at the all the doses and 
in silymarin treatment group after 21 days. 
On the day of 21st enzymatic and non-
enzymatic antioxidant components levels 
significantly increased with co 
administration of MPA at the higher dose 
(500 mg/kg) and in silymarin treated group.  
 
The inhibitory effect of RCIN and INH on 
cytochrome P450 and Cyt c reductase levels 
was also compensated by the extract through 
maintenance of its normal level. The role of 
the MPA in the protection of RCIN and INH 
amediated loss in cytochrome P450 content 
may be considered as an indication of 
improved protein synthesis in hepatic tissue 
(30,31). The function of GST is divided into 
catalysis and binding. GST is a soluble 
protein, plays an important role in the 
detoxification and excretion of  xenobiotics 
(32,33). GST catalyzes the conjugation of 
the thiol functional groups of glutathione to 
electrophylic xenobiotics and results in 
increasing solubility. The xenobiotic–GSH 
conjugate is then either eliminated or 
converted to mercapturic acid.  
 
Another function of GST is the binding 
between GST and endogenous and 
exogenous substances. Since GST increases 
solubility of hydrophobic substances, it 
plays an important role in storage and 
excretion of xenobiotics. MPA which 
decrease the activity of GST, which 
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metabolizes toxic compounds to non-toxic 
compounds, means they have an increasing 
protective activity of the liver. In RCIN and 
INH intoxicated rats, the activity of GST 
increased drastically compared to that of 
normal group. The activity of GST 
recovered significantly (P<0.001) at 250 and 
500 mg/kg of MPA compared to that of 
RCIN and INH group. In contrast, the GST 
activity at 500 mg/kg is almost similar to the 
activity shown by silymarin, a potent 
hepatoprotective agent. 
 
Histopathological studies, treatment with 
different doses of MPA produced mild portal 
triaditis and absence of necrosis when 
compared with control. Treatment with 
silymarin also shows mild portal triaditis and 
absence of necrosis and vacuoles. All these 
results indicate a hepatoprotective potential 
of the extract. The results of the present 
study suggested that MPA possess 
hepatoprotective activity against the 
hepatotoxicity induced by the combination 
of two antitubercular drugs. 
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